Clinical Overview: Rivaroxaban (Xarelto) for Multiple Cardiovascular Conditions - Pharmacy Times

6/30/2022 12:00:00 AM2 years 10 months ago
by Tigris Haran, PharmD
by Tigris Haran, PharmD
Rivaroxaban is the only FDA-approved anticoagulant used in patients with peripheral artery disease and coronary artery disease.
Rivaroxaban (Xarelto) is an anticoagulant approved for multiple conditions, such as nonvalvular atrial fibrillation, treatment and prevention of venous thromboembolism, and other indications categori… [+6845 chars]
full article...